| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/05/2014 | CN102028947B Inhibitor, inhibitor composition and inhibiting method of FAM3B gene, fatty liver treatment method and pharmaceutical application of inhibitor |
| 02/04/2014 | US8642753 Modulation of glucagon receptor expression |
| 02/04/2014 | US8642747 Genetic modification of targeted regions of the cardiac conduction system |
| 02/04/2014 | US8642739 Nuclear factor κB inducing factor |
| 02/04/2014 | US8642571 Therapeutic uses of inhibitors of RTP801 |
| 02/04/2014 | US8642570 ASLV vector system |
| 02/04/2014 | US8642259 Method for identifying substances capable of modulating the activity of a target molecule |
| 02/04/2014 | US8642257 Vaccinia virus for diagnosis and therapy of tumors |
| 02/04/2014 | US8642045 Recombinant virus vector originating in HHV-6 or HHV-7, method of producing the same, method of transforming host cell using the same, host cell transformed thereby and gene therapy method using the same |
| 02/04/2014 | US8642037 Antibodies to insulin-like growth factor I receptor |
| 02/04/2014 | US8642028 Recombinant adenoviruses encoding the specific iodine transporter (NIS) |
| 02/04/2014 | US8642010 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| 02/04/2014 | CA2807515C Alphavirus particles and methods for preparation |
| 02/04/2014 | CA2516727C Hypoxia inducible vegf plasmid for ischemic disease |
| 02/04/2014 | CA2453470C Use of follistatin for the treatment of hepatic fibrogenesis |
| 02/04/2014 | CA2442533C A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 02/04/2014 | CA2432797C Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 02/04/2014 | CA2410263C Purification of a triple helix formation with an immobilized oligonucleotide |
| 02/04/2014 | CA2358860C Dna-binding protein yb-1-containing collagen accumulation inhibitors |
| 02/04/2014 | CA2326388C A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 02/04/2014 | CA2301879C Tuberculosis vaccine |
| 01/30/2014 | WO2014018931A1 Methods and compositions for treating autoimmune disease |
| 01/30/2014 | WO2014018851A1 Predicting and treating diabetic complications |
| 01/30/2014 | WO2014018832A1 Genetically modified probiotic for the treatment of phenylketonuria (pku) disease |
| 01/30/2014 | WO2014018423A2 Inducible dna binding proteins and genome perturbation tools and applications thereof |
| 01/30/2014 | WO2014018295A1 Therapeutic anti-virus vlps |
| 01/30/2014 | WO2014018259A1 Implants and procedures for promoting autologous stem cell growth |
| 01/30/2014 | WO2014017462A1 Pharmaceutical composition for inhibiting abnormal spine formation |
| 01/30/2014 | WO2014016580A1 Transgene expression |
| 01/30/2014 | WO2014015367A1 Polymers for sirna delivery |
| 01/30/2014 | WO2013173129A3 Treatment of amd using aav sflt-1 |
| 01/30/2014 | WO2013163628A3 Genetic correction of mutated genes |
| 01/30/2014 | WO2013163303A3 Transferrin receptor aptamers and aptamer-targeted delivery |
| 01/30/2014 | WO2013086125A3 Method of inducing immune tolerance through targetted gene expression |
| 01/30/2014 | US20140030192 Functional Targeted Brain Endoskeletonization |
| 01/29/2014 | EP2688595A2 Lin28-mediated control of let-7 biogenesis |
| 01/29/2014 | EP2688594A2 Methods and compositions for the treatment of cancer |
| 01/29/2014 | EP2688585A1 Methods and compositions for improving antiangiogenic therapy with anti-integrins |
| 01/29/2014 | EP1196638B1 Use of the krit1 gene in angiogenesis |
| 01/29/2014 | CN103547284A Immunity inducing agent |
| 01/29/2014 | CN103547281A Compositions and methods for the treatment and prevention of cardiac ischemic injury |
| 01/29/2014 | CN103540655A Application of MK5 gene for screening anti-liver cancer drug |
| 01/29/2014 | CN103540654A Applications of 11-19 lysine-rich leukemia (ELL) gene and expression product thereof |
| 01/29/2014 | CN103540653A Applications of homeobox A1 (HOXA1) gene and expression product thereof |
| 01/29/2014 | CN103540616A Lentiviral vector system for expressing diphtheria toxin A (DTA) fragment as well as preparation method and application thereof |
| 01/29/2014 | CN103540591A SiRNA for lowering zinc finger protein A20 expression, and use thereof |
| 01/29/2014 | CN103536934A Self-assembled nano-gene vector compound based on PAMAM (Poly Amido-Amine) and preparation method thereof |
| 01/29/2014 | CN103536933A New application of siRNA (small interfering ribonucleic acid) of neural differentiation related gene BRSK2 |
| 01/29/2014 | CN103536932A Use of SLC17A5 gene and coded protein thereof in preparing medicines for treating or diagnosing nitrate transfer or metabolic block or disorder related diseases |
| 01/29/2014 | CN103536920A Pharmaceutical composition for inhibiting pancreatic cancer cell proliferation and application thereof |
| 01/29/2014 | CN103536911A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| 01/29/2014 | CN102382845B Method for producing porcine parvovirus antigen and its product |
| 01/28/2014 | US8637656 Nucleic acid capable of binding to immunoglobulin G and use thereof |
| 01/28/2014 | US8637484 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 01/28/2014 | US8637482 Methods for treating chronic kidney disease |
| 01/28/2014 | US8637480 Mitochondrial function-improving agent |
| 01/28/2014 | US8637479 Compounds and methods for the treatment of inflammatory diseases of the CNS |
| 01/28/2014 | US8637478 Compounds and methods for modulating protein expression |
| 01/28/2014 | US8637477 Antigenic compositions and use of same in the targeted delivery of nucleic acids |
| 01/28/2014 | US8637043 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 01/28/2014 | US8637020 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof |
| 01/28/2014 | US8637006 Recombinant vaccines and use thereof |
| 01/28/2014 | CA2616877C Systems and methods for manufacturing liposomes |
| 01/28/2014 | CA2533259C Acellular tissue matrices made from galactose .alpha.-1,3-galactose-deficient tissue |
| 01/23/2014 | WO2014015334A1 System and methods for nanostructure protected delivery of treatment agent and selective release thereof |
| 01/23/2014 | US20140024702 Cancer gene therapy using nucleic acids encoding us28 and g-protein |
| 01/23/2014 | US20140024599 Methods and compositions for treatment of disease or injury of the nervous system |
| 01/23/2014 | US20140023711 Bioactive surface capable of genetically modifying biological cells or tissues and use thereof |
| 01/22/2014 | EP2687204A1 Vector for pulmonary delivery, inducing agent, and uses |
| 01/22/2014 | EP2686021A2 Oral formulations for promoting cellular purification |
| 01/22/2014 | CN103534593A The use anti-CXCL16 and anti- CXCR6 antibodies for the treatment or detecting cancer |
| 01/22/2014 | CN103534355A Vectors conditionally expressing protein |
| 01/22/2014 | CN103525941A Application of CTHRC1 genes in preparation of drugs for detecting/treating cervical cancer |
| 01/22/2014 | CN103525905A Application of miRNA in preparation of medicaments and diagnostic reagents for treating primary aldosteronism adenoid tumors |
| 01/22/2014 | CN103525900A Nucleic acid suppression molecule for suppressing expression of brain eIF6 gene and screening method and application thereof |
| 01/22/2014 | CN103524624A Newcastle disease virus and duck circovirus fusion protein as well as coding gene and application thereof |
| 01/22/2014 | CN103520740A Liver fibrosis treatment method |
| 01/22/2014 | CN103520724A Novel application of inhibitor for protein HSD17B13 or coding genes thereof |
| 01/22/2014 | CN103520703A Application of eIF6 in detection, prevention or treatment of exercise-induced fatigue or memory loss |
| 01/21/2014 | US8633305 Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules |
| 01/21/2014 | US8633028 dsRNA induced specific and non-specific immunity in crustaceans and other invertebrates and biodelivery vehicles for use therein |
| 01/21/2014 | US8632997 RNA sequence-specific mediators of RNA interference |
| 01/21/2014 | US8632820 Compositions for achieving a therapeutic effect in an anatomical structure |
| 01/21/2014 | US8632797 Targeted delivery of therapeutic agents with lyophilized matrices |
| 01/21/2014 | US8632764 Directed evolution and in vivo panning of virus vectors |
| 01/21/2014 | CA2739604C Targeted liposome gene delivery |
| 01/21/2014 | CA2638757C Chimeric adenoviral vectors |
| 01/21/2014 | CA2522637C Modified irna agents |
| 01/21/2014 | CA2427257C Expression vectors able to elicit improved immune response and methods of using same |
| 01/21/2014 | CA2414374C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/21/2014 | CA2388477C Recombinant gelatins with uniform molecular weight |
| 01/21/2014 | CA2378437C Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 01/21/2014 | CA2371995C Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 01/21/2014 | CA2359317C Method of treating restenosis by antisense targeting of c-myc |
| 01/21/2014 | CA2236868C Conditionally replicating viral vectors and their use |
| 01/16/2014 | WO2014012081A2 Chiral control |
| 01/16/2014 | WO2014012001A2 Use of cart19 to deplete normal b cells to induce tolerance |
| 01/16/2014 | WO2014011993A2 Epitope spreading associated with car t-cells |
| 01/16/2014 | WO2014011988A2 Enhancing activity of car t cells by co-introducing a bispecific antibody |
| 01/16/2014 | WO2014011975A2 Micrornas sensitize cancers to therapy |